| abstract |
The present invention relates to a method for stereoselectively producing compounds of the formulas (1A) and (1B) and the salts thereof, particularly the physiologically compatible salts thereof having inorganic or organic acids and bases, comprising valuable pharmacological properties, particularly an inhibiting effect on signal transduction mediated by tyrosine kinases, the use thereof for treating diseases, particularly tumor diseases and benign prostata hyperplasia (BPH), and diseases of the lungs and airway. |